Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
VTP-50469
i
Other names:
VTP-50469, SDNX-50469
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(5)
News
Trials
Company:
AbbVie, Syndax Pharma
Drug class:
Menin-MLL inhibitor
Related drugs:
‹
revumenib (18)
ziftomenib (13)
BMF-219 (10)
MI-503 (4)
JNJ-6617 (4)
DS-1594 (3)
D0060-319 (1)
MI-2 (1)
DSP-5336 (1)
revumenib (18)
ziftomenib (13)
BMF-219 (10)
MI-503 (4)
JNJ-6617 (4)
DS-1594 (3)
D0060-319 (1)
MI-2 (1)
DSP-5336 (1)
›
Associations
(5)
News
Trials
VERI cancer hierarchy
Reset Filters
NUP98-KDM5A fusion
Acute Myelogenous Leukemia
NUP98-KDM5A fusion
Acute Myelogenous Leukemia
VTP-50469
Sensitive: D – Preclinical
VTP-50469
Sensitive
:
D
VTP-50469
Sensitive: D – Preclinical
VTP-50469
Sensitive
:
D
NUP98-NSD1 fusion
Acute Myelogenous Leukemia
NUP98-NSD1 fusion
Acute Myelogenous Leukemia
VTP-50469
Sensitive: D – Preclinical
VTP-50469
Sensitive
:
D
VTP-50469
Sensitive: D – Preclinical
VTP-50469
Sensitive
:
D
NPM1 expression
Acute Myelogenous Leukemia
NPM1 expression
Acute Myelogenous Leukemia
VTP-50469
Sensitive: D – Preclinical
VTP-50469
Sensitive
:
D
VTP-50469
Sensitive: D – Preclinical
VTP-50469
Sensitive
:
D
KMT2A expression
Acute Myelogenous Leukemia
KMT2A expression
Acute Myelogenous Leukemia
VTP-50469
Sensitive: D – Preclinical
VTP-50469
Sensitive
:
D
VTP-50469
Sensitive: D – Preclinical
VTP-50469
Sensitive
:
D
MLL rearrangement
Leukemia
MLL rearrangement
Leukemia
VTP-50469 + EPZ-5676
Sensitive: D – Preclinical
VTP-50469 + EPZ-5676
Sensitive
:
D
VTP-50469 + EPZ-5676
Sensitive: D – Preclinical
VTP-50469 + EPZ-5676
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.